OOIR: Observatory of International Research

Papers

(The TQCC of Allergology International is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Subtypes of atopic dermatitis: From phenotype to endotype	119
Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors	90
Skin microbiome of atopic dermatitis	79
Allergy to COVID-19 vaccines: A current update	63
Hydrogen sulfide as a novel biomarker of asthma and chronic obstructive pulmonary disease	53
Peripheral itch sensitization in atopic dermatitis	51
Immune-related adverse events in various organs caused by immune checkpoint inhibitors	50
The multiple functions and subpopulations of eosinophils in tissues under steady-state and pathological conditions	49
How to detect eosinophil ETosis (EETosis) and extracellular traps	48
Skin barrier defects in atopic dermatitis: From old idea to new opportunity	42
Mechanisms of toxicity mediated by neutrophil and eosinophil granule proteins	37
Biologics for severe asthma: The real-world evidence, effectiveness of switching, and prediction factors for the efficacy	37
Eosinophils: Cells known for over 140 years with broad and new functions	33
Executive summary: Japanese guidelines for adult asthma (JGL) 2021	30
Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment	29
Gut microbiota and allergic diseases in children	29
Effect of oral immunotherapy in children with milk allergy: The ORIMA study	29
Chronic urticaria and the pathogenic role of mast cells	29
Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2021	27
Hyper-IgE syndrome, 2021 update	27
Role of intracellular zinc in molecular and cellular function in allergic inflammatory diseases	26
Exacerbating factors and disease burden in patients with atopic dermatitis	25
Screening and diagnosis of acute and chronic bird-related hypersensitivity pneumonitis by serum IgG and IgA antibodies to bird antigens with ImmunoCAP®	24
Early introduction of very small amounts of multiple foods to infants: A randomized trial	22
The diagnosis and treatment of hereditary angioedema patients in Japan: A patient reported outcome survey	21

Executive summary: Japanese guidelines for allergic rhinitis 2020	21
Individual characteristics and associated factors of hay fever: A large-scale mHealth study using AllerSearch	20
Neuro-allergology: Mast cell–nerve cross-talk	19
Current summary of clinical studies on anti-TSLP antibody, Tezepelumab, in asthma	18
Control of immunity and allergy by steroid hormones	18
Drug-induced scleroderma-like lesion	18
Maternal exposure to smoking and infant's wheeze and asthma: Japan Environment and Children's Study	18
Two cases of dupilumab-associated eosinophilic pneumonia in asthma with eosinophilic chronic rhinosinusitis: IL-5-driven pathology?	17
Executive summary: Japanese guidelines for allergic conjunctival diseases 2021	17
Trained innate lymphoid cells in allergic diseases	17
Conventional type 2 lung dendritic cells are potent inducers of follicular helper T cells in the asthmatic lung	17
Identification of peroxidase-1 and beta-glucosidase as cross-reactive wheat allergens in grass pollen-related wheat allergy	16
Comparison of sensitization and prevalence of Japanese cedar pollen and mite-induced perennial allergic rhinitis between 2006 and 2016 in hospital workers in Japan	16
Mortality and risk factors on admission in toxic epidermal necrolysis: A cohort study of 59 patients	16
In vivo visualization of eosinophil secretion in eosinophilic granulomatosis with polyangiitis: An ultrastructural study	16
Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines	16
Prevention of IL-6 signaling ameliorates toluene diisocyanate-induced steroid-resistant asthma	15
Cycling therapy with benralizumab and dupilumab for severe eosinophilic asthma with eosinophilic chronic rhinosinusitis and eosinophilic otitis media	14
Multiplex component-based allergen macroarray test is useful to predict clinical reactivity to tree nuts in children	14
Respiratory sensitization to insect allergens: Species, components and clinical symptoms	14
Comprehensive hospital-based regional survey of anaphylaxis in Japanese children: Time trends of triggers and adrenaline use	14
Benralizumab as initial treatment for chronic eosinophilic pneumonia	14
Efficacy of a house dust mite sublingual immunotherapy tablet as add-on dupilumab in asthma with rhinitis	14
The understanding of asthma pathogenesis in the era of precision medicine	13
Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma	13
ILC2s in skin disorders	13
Impact of the COVID-19 pandemic on asthma exacerbations in children: A multi-center survey using an administrative database in Japan	13
Drug allergy and autoimmune diseases	13
Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case–control and cohort studies	12
Thymus and activation-regulated chemokine (TARC/CCL17) predicts decline of pulmonary function in patients with chronic obstructive pulmonary disease	12
Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma: A post-marketing surveillance	12
ORMDL3/GSDMB genotype as a risk factor for early-onset adult asthma is linked to total serum IgE levels but not to allergic sensitization	12
Neurodevelopment at 6 years of age in children with atopic dermatitis	12
Direct and indirect action modes of acetylcholine in cholinergic urticaria	12
Treatments of refractory eosinophilic lung diseases with biologics	12
Optimal Aspergillus fumigatus and Asp f 1 serum IgG cut-offs for the diagnosis of allergic bronchopulmonary aspergillosis	11
The effects of mepolizumab on peripheral circulation and neurological symptoms in eosinophilic granulomatosis with polyangiitis (EGPA) patients	11
Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks	11
Biologics for allergy: therapeutic potential for ocular allergic diseases and adverse effects on the eye	11
Frailty and muscle weakness in elderly patients with asthma and their association with cumulative lifetime oral corticosteroid exposure	11
Relationship between Aspergillus and asthma	10
Multi-faceted regulation of IgE production and humoral memory formation	10
Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress	10
Dupilumab-resistant facial erythema - Dermoscopic, histological and clinical findings of three patients	10
Cord blood eosinophilia precedes neonatal onset of food-protein-induced enterocolitis syndrome (FPIES)	10
Neuro-immune crosstalk and food allergy: Focus on enteric neurons and mucosal mast cells	10
Low-dose oral immunotherapy for walnut allergy with anaphylaxis: Three case reports	10
Components of plant-derived food allergens: Structure, diagnostics, and immunotherapy	9
Activated steady status and distinctive FcεRI-mediated responsiveness in basophils of atopic dermatitis	9
Contribution of monocyte and macrophage extracellular traps to neutrophilic airway inflammation in severe asthma	9

Classifications of moderate to severe asthma phenotypes in Japan and analysis of serum biomarkers: A Nationwide Cohort Study in Japan (NHOM Asthma Study)	9
Drug allergy and non-HIV immune reconstitution inflammatory syndrome	9
Poorly controlled asthma – Easy wins and future prospects for addressing fungal allergy	9
Combined assessment of serum eosinophil-derived neurotoxin and YKL-40 may identify Asthma-COPD overlap	9
Prevalence of inhaled allergen-specific IgE antibody positivity in the healthy Japanese population	9
Time will tell about mast cells: Circadian control of mast cell activation	9
Group 2 innate lymphoid cells in human asthma	9
A validation study of the Japanese version of the Angioedema Activity Score (AAS) and the Angioedema Quality of Life Questionnaire (AE-QoL)	8
Primary and pollen-associated hazelnut allergy in school-aged children in Germany: A birth cohort study	8
Inborn errors of immunity with eosinophilia	8
Asthma exacerbation associated with COVID-19 pneumonia	8
Interstitial pneumonitis after COVID-19 vaccination: A report of three cases	8
The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases	8
Clinical characteristics of patients with not well-controlled severe asthma in Japan: Analysis of the Keio Severe Asthma Research Program in Japanese population (KEIO-SARP) registry	8
Efficacy of dupilumab for airway hypersecretion and airway wall thickening in patients with moderate-to-severe asthma: A prospective, observational study	8
Periostin is an aggravating factor and predictive biomarker of eosinophilic chronic rhinosinusitis	8
Efficacy of dupilumab and biomarkers for systemic corticosteroid naïve allergic bronchopulmonary mycosis	8
Propolis suppresses cytokine production in activated basophils and basophil-mediated skin and intestinal allergic inflammation in mice	8
Regional differences in the incidence of asthma exacerbations in Japan: A heat map analysis of healthcare insurance claims data	8
S100A8 enhances IL-1β production from nasal epithelial cells in eosinophilic chronic rhinosinusitis	8
Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial	8